A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. (From Martindale, The Extra Pharmacopoeia, 30th ed, p595)
Flupenthixol has been studied across 15 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧘 Stress & Anxiety, 🧠 Learning, 😴 Sleep. The primary research focus is 🌤️ Mood & Depression with 53% of studies addressing this area.
This evidence profile for Flupenthixol is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.